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Background: Shiga toxin-producing Escherichia coli (STEC) is recognized as an important human diarrheal pathogen.
Swine plays an important role as a carrier of this pathogen. In this study we determined the prevalence and
characteristics of STEC from healthy swine collected between May 2011 and August 2012 from 3 cities/provinces
in China.
Results: A total of 1003 samples, including 326 fecal, 351 small intestinal contents and 326 colon contents samples,
was analyzed. Two hundred and fifty five samples were stx-positive by PCR and 93 STEC isolates were recovered from
62 stx-positive samples. Twelve O serogroups and 19 O:H serotypes including 6 serotypes (O100:H20/[H20], O143:H38/
[H38], O87:H10, O172:H30/[H30], O159:H16, O9:H30/[H30]) rarely found in swine and ruminants were identified. All 93
STEC isolates harbored stx2 only, all of which were stx2e subtype including 1 isolate being a new variant of stx2e. 53.76%,
15.05% and 2.15% STEC isolates carried astA, hlyA and ehxA respectively. Four STEC isolates harbored the high-pathogenicity
island. Of the 15 adherence-associated genes tested, 13 (eae, efa1, iha, lpfAO113, lpfAO157/OI-154, lpfAO157/OI-141, toxB, saa, F4, F5,
F6, F17 or F41) were all absent while 2 (paa and F18) were present in 7 and 4 STEC isolates respectively. The majority of the
isolates were resistant to tetracycline (79.57%), nalidixic acid (78.49%), trimethoprim-sulfamethoxazole (73.12%) and
kanamycin (55.91%). The STEC isolates were divided into 63 pulsed-field gel electrophoresis patterns and 21 sequence
types (STs). Isolates of the same STs generally showed the same or similar drug resistance patterns. A higher proportion
of STEC isolates from Chongqing showed multidrug resistance with one ST (ST3628) resistant to 14 antimicrobials.
Conclusions: Our results indicate that swine is a significant reservoir of STEC strains in China. Based on comparison by
serotypes and sequence types with human strains and presence of virulence genes, the swine STEC may have a low
potential to cause human disease.
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Escherichia coli that produces one or more types of cyto-
toxins known as Shiga toxin (Stx) or Verocytotoxin (VT)
is referred to as Shiga toxin-producing E. coli (STEC) or
Verocytoxion-producing E. coli (VTEC) [1]. STEC is a
well-known pathogen as a cause of diarrhea, hemorrhagic
colitis (HC) and hemolytic uremic syndrome (HUS) [2].
Most cases of HC and HUS have been attributed to STEC
O157:H7, but the importance of non-O157 STEC is in-
creasingly recognized [3].
STEC possesses a number of virulence factors. Besides
the stx genes, human pathogenic STEC strains often carry
the eae gene, one of the genes located on LEE pathogen-
icity island encoding the adherence factor intimin [4] and
the astA gene encoding a heat-stable enterotoxin EAST1
[5]. STEC strains may also be hemolytic due to the pres-
ence of the α-hemolysin or the enterohemolysin or both.
The α-hemolysin gene hlyA is located on the chromosome
[6] while the enterohemolysin (ehxA) is harbored by a
plasmid [7]. Many adherence-related factors were found
in STEC [8-13]. EHEC factor for adherence (efa1) was
shown to be essential for the adherence of the bacteria to
cultured epithelial cells [11]. The IrgA homologue adhesin
(iha) is a STEC adherence-conferring molecule conferring
the adherence phenotype upon a nonadherent laboratory
E. coli strain [13]. lpfAO113, lpfAO157/OI-154 and lpfAO157/OI-141
are adhesion genes in LEE-negative STEC strains [9,14].
Many STEC strains contain the heterologous 60-MDa
virulence plasmid, which encodes a potential adhesin
ToxB [10]. Other novel adhesion factors reported in-
clude autoagglutinating adhesin (saa) [12] and porcine
attaching and effacing (A/E) associated protein (paa) [8].
Most STEC strains isolated from diarrheal pigs can produce
one or more of the fimbriae, F4, F5, F6, F17, F18 and F41.
Different types of fimbriae were reported to be associated
with STEC diarrhea in animals of different age groups
[15-18]. The Yersinia high-pathogenicity island (HPI) carry-
ing fyuA (encoding the pesticin receptor) and irp (encoding







Beijing 523 SC (248, 24.73)
CC (275, 27.42)
Chongqing 326 F (326, 32.50)
Guizhou 154 SC (103, 10.27)
CC (51, 5.08)
Total 1003 SC (351, 35.00)
CC (326, 32.50)
F (326, 32.50)
Sample codes: F, fecal samples; CC, colon contents samples; SC, small intestine connon-O157 STEC lineages and was previously reported only
in stx2e carrying human isolates [19].
Domestic ruminants, especially cattle, are the major
reservoirs of STEC. Other animals like sheep, goats have
been confirmed as important natural reservoirs in some
countries [2,20-22]. Swine also play an important role as
a carrier of this pathogen. STEC strains that produce
Stx2e can cause edema disease in pigs [23] and can also
been isolated from human stools at low frequency. STEC
carried by healthy pigs may pose a potential risk to
humans [24-27]. Relatively little is known about the
prevalence and characteristics of STEC in pigs in China.
In this study, we isolated and characterized STEC from
different pig slaughter houses and pig farms from 3
geographical regions, Beijing city, Chongqing city and
Guizhou province in China.
Results
Prevalence of STEC in swine samples
Out of 1003 swine samples collected in this study, 25.42%
(255/1003) were stx-positive by PCR. A total of 93 STEC
isolates was obtained from 62 samples, giving a culture
positive rate of 24.31% (62/255) of all stx-positive samples.
Different stx-positive rates in small intestine contents
(10.83%), colon contents (47.24%) and feces (19.33%) sam-
ples were observed. The colon contents samples gave the
highest stx-positive rate (P < 0.05) and also the highest
culture positive rate (18.09%) (P < 0.05) (Table 1).
Only a single isolate was recovered from 44 stx-positive
samples each. But 2 isolates per sample were recovered
from 15 samples, 3 isolates per sample from 3 samples, 4
isolates per sample from 2 samples and 5 isolates per sam-
ple from 1 sample.
Serogroups and serotypes
The 93 STEC isolates were typed into 19 serotypes,
comprising 12 O serogroups and 15 H types. Forty-four
isolates were O antigen untypable and 21 isolates were






SC (30, 8.55) SC (3, 0.85) SC (7, 1.99)
CC (139, 42.64) CC (36, 11.04) CC (57, 17.48)
F (63, 19.33) F (17, 5.21) F (23, 7.06)
SC (8, 2.28) SC (4, 1.14) SC (4, 1.14)
CC (15, 4.60) CC (2, 0.61) CC (2, 0.61)
SC (38, 10.83) SC (7, 1.99) SC (11, 3.13)
CC (154, 47.24) CC (38, 11.66) CC (59, 18.09)
F (63, 19.33) F (17, 5.21) F (23, 7.06)
tents samples. The number (N) and rate (%) are showed in the parentheses.
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[H30], O20:H30/[H30], O20:H26, O76:H25, O86:H11, O87:
H10, O100:H20/[H20], O114:[H30], O116:H11, O143:H38/
[H38], O159:H16, O172:H30/[H30], ONT:H7, ONT:H17,
ONT:H19/[H19], ONT:H21/[H21], ONT:H30/[H30], ONT:
[H33].
The predominant serotypes were O20:H30/[H30],
ONT:H30/[H30], O2:H32/[H32], O100:H20/[H20], O9:H30/Table 2 Serotypes, virulence factors and sequence types (STs
ST No. of isolates Serotypea stx2e
b
ST10 2 O2:H32/[H32](1CC, 1SC) +
ST88 4 ONT:H19/[H19](1SC, 3CC) +
ST206 3 O143:H38/[H38](3CC) +
ST361
1 O20:H30 (1CC) +
1 ONT:H30 (1CC) +
ST501 2 O86:H11 (2CC) +
ST540
1 ONT:H30 (1SC) +
3 ONT:[H30] ( 1SC, 2CC) +
1 O114:[H30] (1CC) +
ST641 1 O87:H10 (1SC) +
ST694 1 ONT:[H33] (1CC) +
ST710
2 O20:H26 (2 F) +
17 O20:H30/[H30](4 F, 13CC) +
1 O20:[H30] (1 F) +
3 O20:[H30](1 F, 2CC) +
3 O172:H30/[H30](3CC) +
ST953 2 ONT:H17 (2CC) +
ST993
10 ONT:H30 (10CC) +
2 ONT:H30 (2CC) +
3 ONT:H30/[H30](2 F, 1CC) +
ST1294 1 ONT:H30 (1CC) +
ST1494 2 ONT:H21/[H21](2CC) +
ST2514
1 O100:H20 (1 F) +
1 O100:H20 (1SC) +
5 O100:H20/[H20](1 F,4CC) +
1 O100:[H20] (1CC) +
ST3628 9 O2:H32/[H32](9 F) +
ST3629
4 O9:H30/[H30](4CC) +
1 ONT:H30 (1CC) +
ST3630 1 O159:H16 (1CC) -
ST3633 1 O76:H25 (1 F) +
ST3631 1 ONT:H7 (1SC) +
ST3634 1 ONT:H7 (1SC) +
ST3870 1 O116:H11(1 F) +
Total 93 93 93
aThe numbers and sources are showed in the parentheses. F, fecal samples; CC, col
with available O antisera. The H types of non-motility isolates are determined by fliC
bNinety-two STEC isolates were subtyped by primer-specific PCR except one isolate[H30], ONT:H19/[H19], O143:H38/[H38], O172:H30/[H30]
which consisted of 22 (23.66%), 22 (23.66%), 11 (11.83%),
8 (8.60%), 4 (4.30%), 4 (4.30%), 3 (3.23%) and 3 (3.23%)
isolates respectively. Five serotypes (O20:H26, O86:H11,
ONT:H7, ONT:H17, ONT:H21/[H21]) contained 2 iso-
lates each and 6 serotypes (O76:H25, O87:H10, O114:
[H30], O116:H11, O159:H16, ONT:[H33]) contained
only 1 isolate each (Table 2).) of swine STEC isolates
hlyA ehxA astA irp2 fyuA paa F18
- - - - - - -
- - + + + - -
- - - - - - -
- - + - - - -
- - + - - - -
+ - + - - - +
- - - - - - -
- - - - - - -
- - - - - - -
+ - - - - - +
- - + - - - -
- - + - - - -
- - + - - - -
- + + - - + -
- - + - - - -
- - + - - - -
- - - - - + -
- - - - - - -
- - + - - - -
- - - - - - -
- - - - - - -
- - + - - - -
- - + - - - -
- - + - - + -
- - - - - - -
- + - - - + -
+ - - - - - -
- - + - - - -
- - + - - - -
- - + - - + -
+ - - - - - -
- - + - - + -
- - + - - - -
+ - + - - - +
14 2 50 4 4 7 4
on contents samples; SC, small intestine contents samples. ONT, Not typeable
sequencing and indicated in the square brackets.
of O159:H16.
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Out of the 93 STEC isolates, 53 (56.99%) were sorbitol-
positive, covering all three types of samples and three
regions. Twelve serotypes including O2:H32/[H32],
O9:H30/[H30], O20:H26, O76:H25, O86:H11, O87:H10,
O114:[H30], O116:H11, ONT:H17, ONT:H19/[H19], ONT:
H21/[H21], ONT:[H33] were sorbitol-positive while 6
serotypes (O20:H30/[H30], O100:H20/[H20], O143:H38/
[H38], O159:H16, O172:H30/[H30], ONT:H7) were sorb-
itol negative. All except 1 ONT:H30/[H30] isolate was
sorbitol-positive.
Fourteen isolates displayed apparent β-hemolytic activity
on sheep blood agar including 9 of the 11 O2:H32/[H32]
isolates and 2 of the 11 O86:H11 isolates, and the single
O76:H25, O87:H10 and O116:H11 isolates, the majority
of which (11 isolates) were recovered from swine feces in
Chongqing city. The 2 hemolytic O86:H11 isolates were
isolated from colon contents in a slaughter house in
Beijing city and the single O87:H10 isolate was isolated
from a small intestine content in a slaughter house in
Guizhou province.
Shiga toxin genes, adhesin genes and putative virulence
genes
The 93 STEC isolates were tested positive for stx2 only.
All except 1 isolate was stx2e subtype by PCR subtyping.
The exception was an O159:H16 isolate which was
found to carry a new variant of stx2e by sequencing. The
new variant differs from the closest stx2e (GenBank:
AM904726) by 4.51% at nucleotide level.
Three virulence-related genes (astA, ehxA and hlyA)
and 2 markers for HPI (irp2 and fyuA) were screened.
53.76% (50/93) STEC isolates carried astA, 15.05% (14/
93) isolates contained hemolysin gene hlyA and only
2.15% (2/93) isolates contained enterohemolysin gene
ehxA. All hlyA positive STEC isolates showed hemolytic
activity on standard sheep blood agar. Hemolysis was
not observed in the 2 ehxA-positve STEC isolates. The
irp2 and fyuA genes were identified in 4 STEC isolates,
all of which were ONT:H19/[H19] serotypes (Table 2).
Among the 15 adherence-associated genes, 13 (eae, efa1,
iha, lpfAO113, lpfAO157/OI-154, lpfAO157/OI-141, toxB, saa, F4,
F5, F6, F17 or F41) were not detected in the 93 STEC iso-
lates. paa was present in 7 STEC isolates. Two O86:H11
isolates, 1 O87:H10 isolate and 1 O116:H11 isolate carried
F18. Eighty-two STEC isolates did not carry any of the
adherence-associated genes tested (Table 2).
Antibiotic resistance in the swine STEC isolates
Antimicrobial resistance was determined against 23 anti-
biotics. The highest prevalence was tetracycline resist-
ance with a rate of 79.57%. Most isolates were resistant
to nalidixic acid and trimethoprim-sulfamethoxazole,
followed by resistance to kanamycin with a rate of78.49%, 73.12% and 55.91% respectively. Resistance rate
to streptomycin, chloramphenicol, ampicillin and pipera-
cillin was 48.39%, 37.63%, 25.81% and 20.43%, respect-
ively. Lower resistance was observed for cephalothin,
nitrofurantoin, ciprofloxacin, ceftriaxone, aztreonam,
cefotaxime, cefuroxime, gentamicin, norfloxacin, levo-
floxacin, ampicillin-sulbactam with a rate ranging from
2.15% to 17.20%. All isolates were susceptible to imipe-
nem and meropenem (Additional file 1: Table S1).
Four isolates (4.3%) were susceptible to all 23 anti-
microbial agents tested. Thirteen isolates (13.98%) were
only resistant to 1 antimicrobial substance, while 76 iso-
lates (81.72%) exhibited resistance to 2 or more antimi-
crobials tested. The STEC isolated from pig farms in
Chongqing city showed resistance to a larger number of
antimicrobial agents, and at a significantly higher rate
than those isolated from slaughter houses in Beijing city
(P < 0.05) (Figure 1 and Additional file 1: Table S1). An
O116:H11 isolate exhibited multi-drug resistant pheno-
type against 19 of all 23 antimicrobial agents (excluding
imipenem, meropenem, gentamicin and levofloxacin).
Pulsed-field gel electrophoresis (PFGE)
All 93 STEC isolates were analyzed by PFGE but only 88
isolates produced clear bands to give a PFGE profile
which were divided into 63 PFGE patterns (EZKX01001
to EZKX01063). The most prevalent serotype O20:H30/
[H30] with 22 isolates were typed into 16 PFGE patterns
and the 11 O2:H32/[H32] isolates were typed into 8
PFGE patterns. An UPGMA dendrogram was con-
structed (Figure 2). The 88 STEC isolates could be di-
vided into six clusters, A to F, at a similarity of 75% or
greater. Cluster A contains all 4 O9:H30/[H30] and all 3
O100:H20/[H20] isolates. Cluster B contained the ma-
jority of O20:H30 isolates which were grouped into 3
subclusters. All the 11 of O2:H32/[H32] isolates also
fell into cluster B as one subcluster. Cluster C was
heterogenous containing 6 serotypes. Clusters D to F
contained mostly one serotype: O143:H38/[H38], ONT:
H19/[H19], ONT:H30/[H30] respectively. Although iso-
lates were largely grouped together by serotypes, iden-
tical PFGE profiles were also found among isolates
of different serotypes (O20:H30/[H30] and O172:H30/
[H30]) which were not from the same sample but from
the same sampling point.
Multi-locus sequence typing (MLST)
The 93 STEC isolates were typed into 21 sequence types
(STs) with 7 novel STs (Table 2). Four new STs (ST3628,
ST3629, ST3633 and ST3634) were resulted from a novel
allele in fumC (allele 470), gyrB (allele 351), icd (allele 396)
and recA (allele 267) respectively. Three new STs (ST3630,
ST3631 and ST3870) were due to new combinations






































Figure 1 Antimicrobial resistance profiles of the STEC isolates. Three regions sampled are Beijing city (in blue), Chongqing city (in red),
Guizhou province (in green). Statistical test was only performed between Chongqing and Beijing. A *and** were placed above the histogram for
Chonqing samples if P < 0.05 and P < 0.001 respectively. Antibiotics abbreviations are: AMP, Ampicillin; PIP, Piperacillin; AMC, Amoxicillin-clavulanic
acid; SAM, Ampicillin-sulbactam; FEP, Cefepime; CTX, Cefotaxime; CRO, Ceftriaxone; KF, Cephalothin; CXM, Cefuroxime; ATM, Aztreonam; IPM,
Imipenem; MEM, Meropenem; GM, Gentamicin; K, Kanamycin; S, Streptomycin; TE, Tetracycline; CIP, Ciprofloxacin; NOR, Norfloxacin; LVX, Levofloxacin;
NA, Nalidixic acid; SXT, Trimethoprim-sulfamethoxazole; C, Chloramphenicol; F, Nitrofurantoin.
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isolates respectively. Six STs contained 3 or more isolates
with ST3628, ST2514, ST540, ST3629, ST88 and ST206
comprising 9 (9.68%), 8 (8.60%), 6 (6.45%), 5 (5.38%), 4
(4.30%) and 3 (3.23%) isolates respectively. Five STs (ST10,
ST361, ST1494, ST953 and ST501) contained 2 isolates
each. Eight STs (ST641, ST691, ST1294, ST3630, ST3631,
ST3633, ST3634 and ST3870) had only 1 isolate each.
STEC isolates from Beijing, Chongqing and Guizhou were
typed into 14, 6 and 5 STs respectively. ST2514 were
recovered from all 3 regions and ST710 and ST993 were
recovered from 2 regions, while other STs was only found
in one region.
A minimum spanning tree was constructed (Figure 3A).
Most STs differed from each other by 2 or more alleles
while three pairs of STs (ST10 and ST3628, ST540 and
ST3629, and ST88 and ST3870) and one set of 3 STs
(ST3630, ST3631 and ST3634) differed from each other
by only 1 allele. There is good concordance between STs
and serotype. One ST consisted of solely or predominantly
one serotype. However ST710, the most frequent ST,
contained 3 serotypes, O20:H30/[H30], O172:H30/[H30]
and O20:H26 with the first serotype being predominant.
PFGE and MLST were also largely consistent in the clus-
tering of the isolates (Figure 2). ST540 and ST3629 with 1
SNP difference in icd allele were grouped together with
ST2514 in PFGE cluster A. All ST710 isolates were
grouped into 2 subclusters within PFGE cluster B whichwere separated by ST3628, ST10 and ST1294. ST10 and
ST3628 isolates were grouped together which differed by
1 SNP difference in gyrB. PFGE clusters D and F were
inclusive of all ST206 isolates and ST993 isolates re-
spectively. However, the 5 STs (ST361, ST501, ST953,
ST1494 and ST3633) within PFGE cluster C and the
3 STs (ST88, ST3631 and ST694) within PFGE cluster
E were not closely related to each other by MLST
(Figure 3A). On the other hand, ST88 was not grouped
together with ST3870 by PFGE, which differed by 1
SNP difference in gyrB. The sole ST3870 isolate C09
also differed from the 4 ST88 isolates by serotype,
hemolysis and antibiotic resistance profile.
Isolates of the same STs generally showed the same
or similar drug resistance patterns (Figure 2). All
ST3628 isolates showed the same multi-drug resistance
to 14 antibiotics. Similarly, isolates of ST206, ST953and
ST1494 showed respective identical resistance profiles.
All ST3629 isolates were resistant to tetracycline. How-
ever there existed variations of drug resistance within an
ST. ST710 showed the most variability with resistance to
1 to 11 drugs. ST2514 which was isolated from all 3
regions also showed varied resistance profiles.
Discussion
Different prevalence of STEC in pigs were reported previ-
ously [24,25,27-29]. Kaufmann et al. [24] compared the
STEC shedding rate in pigs at slaughter, which varied




non-O157 STEC Serotype hemolysis SOR STSimilarity (%)
ONT:H30 - + ST540 S, TE, NA, SXT
ONT:[H30] - + ST540 S, TE, NA, SXT
ONT:H30 - + ST540 TE
O114:[H30] - - ST540 /
ONT:[H30] - + ST540 /
O9:H30 - + ST3629 TE
O9:[H30] - + ST3629 TE
O9:H30 - + ST3629 TE
ONT:H30 - + ST3629 TE
O9:H30 - + ST3629 TE
O100:[H20] - - ST2514 C, AMP, F, PIP, S, TE, N A, KF
O100:[H20] - - ST2514 C, K, TE, NA, SXT
O100:H20 - - ST2514 TE
O159:H16 - - ST3630 TE, NA
O20:H30 - - ST710 K, S, TE, NA, SXT
O20:H30 - - ST710 GM, C, AMP, CIP, K, S, TE, NA, NOR, SXT, LVX
O20:H30 - - ST710 K, S, TE, NA, SXT
O20:[H30] - - ST710 K, S, TE, NA, SXT
O20:H30 - - ST710 TE, NA, SXT
O20:H30 - - ST710 NA, SXT
O20:H30 - - ST710 NA, SXT
O172:[H30] - - ST710 TE, NA, SXT
O172:H30 - - ST710 TE, NA, SXT
O20:H30 - - ST710 NA, SXT
O20:H30 - - ST710 NA, SXT
O20:[H30] - - ST710 NA, SXT
O20:H30 - - ST710 NA
O20:H30 - - ST710 C, K, TE, NA, SXT
O20:H30 - - ST710 TE, NA, SXT
O20:H30 - - ST710 TE, NA, SXT
O20:H30 - - ST710 TE, NA, SXT
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:[H32] + + ST3628
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:H32 + + ST3628
O2:[H32] - + ST10 GM, C, AMP, CIP, K, PI P, S, TE, NA, SXT
O2:H32 - + ST10 GM, C, AMP, CIP, K, PIP , S, TE, NA, SXT
ONT:H30 - + ST1294 GM, C, AMP, K, F, S, TE, NA, SAM, SXT
O20:H26 - + ST710 /
O20:H26 - + ST710 /
O172:H30 - - ST710 C, K, TE, SXT
ONT:H7 - - ST3634 C, K, TE, NA, SXT
O20:[H30] - - ST710 C, K, S, TE, NA, SXT
O20:[H30] - - ST710 C, K, S, TE, NA, SXT
O20:H30 - - ST710 C, K, TE, SXT
O20:[H30] - - ST710 C, K, SXT
O20:[H30] - - ST710 C, K, SXT
O20:H30 - - ST710 C, K, TE, SXT
ONT:H30 - - ST361 GM, AMP, CIP, K, PIP, S , TE, NA, NOR, SXT, LVX
O20:H30 - - ST361 GM, AMP, CIP, PIP, S, TE, NA, NOR, SXT, LVX, KF
O86:H11 + + ST501 C, AMP, CIP, K, F, PIP, S, TE, NA, NOR, SXT, LVX, KF
O86:H11 + + ST501 C, AMP, CIP, K, PIP, S, TE, NA, NOR, SXT, LVX, KF
O76:H25 + + ST3633 C, K, F, S, TE, NA, SXT
ONT:H17 - + ST953 C, K, S, TE, NA, SXT
ONT:H17 - + ST953 C, K, S, TE, NA, SXT
ONT:H21 - + ST1494 TE, NA
ONT:[H21] - + ST1494 TE, NA
O143:H38 - - ST206 CIP, K, TE, NA, SXT
O143:[H38] - - ST206 CIP, K, TE, NA, SXT
O143:H38 - - ST206 CIP, K, TE, NA, SXT
ONT:H19 - + ST88 AMP, S, TE, NA, SXT
ONT:H19 - + ST88 S, TE, NA, SXT
ONT:[H19] - + ST88 AMP, PIP, S, TE, NA, SXT, KF
ONT:H19 - + ST88 AMP, PIP, NA, SXT
ONT:H7 - - ST3631 TE, NA
ONT:[H33] - + ST694 C, CIP, K, S, TE, NA, NO R, SXT, LVX
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:[H30] - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 GM, C, AMP, K, S, TE, N A
ONT:H30 - + ST993 GM, C, AMP, CIP, K, S, TE, NA
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, CRO, SXT
ONT:[H30] - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, S, TE, NA, SXT
ONT:H30 - + ST993 K, NA, SXT
ONT:H30 - + ST993 C, K, TE, SXT
ONT:H30 - + ST993 C, K, SXT
O87:H10 + + ST641 TE, KF
O116:H11 + + ST3870 AMC, ATM, C, FEP, AM P, CTX, CIP, K, F, PIP, S,

































































































ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
ATM, C, AMP, CTX, K, F, PIP, S, TE, NA, CRO, SXT, KF, CXM
Figure 2 (See legend on next page.)
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Figure 2 Dendrogram of PFGE profiles of 88 STEC isolates from pigs in farms and slaughter houses. The 6 PFGE clusters were marked on
the node as A to F. Non-typeable with available O antisera was marked ONT and non-motile isolates were labeled with the H types in square
brackets. Displayed on the right hand side are strain name, sample name, serotype, hemolysis, sorbitol fermentation (SOR), sequence type (ST) and
antibiotic resistance. Abbreviations for antibiotics are: AMP, Ampicillin; PIP, Piperacillin; AMC, Amoxicillin-clavulanic acid; SAM, Ampicillin-sulbactam; FEP,
Cefepime; CTX, Cefotaxime; CRO, Ceftriaxone; KF, Cephalothin; CXM, Cefuroxime; ATM, Aztreonam; IPM, Imipenem; MEM, Meropenem; GM, Gentamicin; K,
Kanamycin; S, Streptomycin; TE, Tetracycline; CIP, Ciprofloxacin; NOR, Norfloxacin; LVX, Levofloxacin; NA, Nalidixic acid; SXT, Trimethoprim-sulfamethoxazole;
C, Chloramphenicol; F, Nitrofurantoin. Place of isolates were contained in the first letter of strain names: B means Beijing city, C means Chongqing city and
G means Guizhou province.
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http://www.biomedcentral.com/1471-2180/14/5widely and ranged from 2.1% to 70% depending on the
health conditions of the pigs and the detection method
used. As shown in this study the anatomic sites sampled
also affected the rate of isolation and consequently af-
fected the prevalence in the population reported. Fecal
samples were commonly used [24-26]. In our study we
sampled the small intestinal content, the colon content
and the feces. The prevalence of STEC in the colon
(47.24%) was almost 2.5 times higher than in feces
(19.33%) (P < 0.05) and 4.4 times higher than in the small
intestine (10.83%) (P < 0.05). STEC strains are thought to
mostly colonize the colons of humans [30] and it is likely
to be the same for pigs.
In this study, 93 isolates were recovered from 62 of
the 255 stx-positive samples, giving a culture positve rate
of 24.31%, this result is similar to that of Botteldoorn
et al. [28], in which STEC isolates were obtained from
31% of the stx PCR-positive pig samples. Failure to iso-
late STEC from the stx-positive samples may due to the
perturbation of high levels of background microflora,
the loss of Stx prophages during subculture, the pres-
ence of other bacteria carrying stx or low levels of STEC
in the samples.
In the present study, 12 serogroups and 19 serotypes
were identified. The majority of these serotypes have
been isolated from swine, sheep, cattle, food, and water in
other countries [24,31-36]. The most prevalent serotype is
O20:H30/[H30], which was also reported in cattle and
sheep in different countries [31,32]. Six serotypes (O100:
H20/[H20], O143:H38/[H38], O87:H10, O172:H30/[H30],
O159:H16, O9:H30/[H30]) were rarely found in STEC iso-
lates isolated from swine and other ruminants, implying
that these serotypes may be restricted to the swine popula-
tions in these regions and their environments. Serotypes
O86:H11, O20:NM, O100:NM, O9:NM, O172:NM and
O114:NM have previously been described among STEC
isolated from human patients [37-42]. Serotype O157:H7,
which is common serotype causing human disease in
some countries, was not detected.
A possible reason for no isolation of O157:H7 might
be the method used. Isolation of O157 STEC often re-
quires more targeted methods, such as the use of O157
immunomagnetic beads to capture the bacteria from en-
richment broth and then culture on selective media [43].We previously used immunomagnatic separation to suc-
cessfully isolate O157 STEC from pigs, although that
was in an outbreak setting and was in a different geo-
graphic region [44]. In this study we used CHROMagar™
ECC only and didn’t specifically target O157 STEC.
CHROMagar™ ECC has been used by others for isolation
of STEC from pigs [45]. However, that study did not iso-
late O157 STEC either. Therefore, the CHROMagar™ ECC
may not be an ideal media for O157 STEC isolation.
We used sorbitol-MacConkey agar as a quick method
to pick potential O157 colonies since sorbitol fermenta-
tion is a traditional feature for differentiating O157:H7
which is sorbitol-negative although there are sorbitol-
positive O157 STEC [46]. In this study, a fair proportion
(43%) of non-O157 STEC is actually sorbitol-negative.
Therefore sorbitol fermentation is not a good indicator
for O157:H7.
We analyzed multiple colonies from 21 samples to de-
termine diversity within a sample (Figure 2). Two samples
contained isolates with identical properties, suggesting
they are the same strain, while the majority of the samples
contain isolates belonging to the same sequence type but
differing by one or more of the phenotypic or genetic
properties tested, indicating that they are variants of the
same clone. The most common variations are non-
expression of the H antigen, variation of antibiotic resist-
ance and/or variation in PFGE patterns. However 4 sam-
ples contained 2 different STs. Samples S15, S41, S49 and
S50 all contain the prevalent ST993 and an additional ST,
being ST10, ST88, ST710 and ST540 respectively, suggest-
ing 2 different clones infecting the same pig.
Many studies have underlined the potential key role of
the Stx2 subtypes in the severity of disease. Although
Stx2e is not a potent subtype [47], strains harboring Stx2e
have been isolated from patients with diarrhea [48]. Inti-
min contributes to the development of A/E lesions and is
a key virulence for some STEC serotypes [49], while ehxA
can be found in many STEC serotypes, such as O157:H7
and O26:H11 that are associated with diarrheal disease
and HUS [7,50]. However, Sonntag et al. reported that the
stx2e-positive E. coli isolated from healthy pigs rarely con-
tains genes for intimin and enterohemolysin [19]. The
prevalence of ehxA is very low in our samples at 2.15%,
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Human STEC STs in the E. coli MLST database 
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HUSEC collection STs





Figure 3 Genetic relationships of STEC isolates based on MLST. A) Genetic relationships of STEC sequence types (STs) from this study. Each
circle represents a given ST with size proportional to the number of isolates. The colors for the slices of the pie represent places of isolates: Beijing city
in green, Chongqing city in red and Guizhou province in purple. The numbers on connecting lines show the number of allelic difference between two
STs. The number in a circle is the ST number. B) Minimal spanning tree of STs from this study, STs from the HUSEC collection and other human
STEC STs. Ninety-three pig STEC isolates (in red) were compared to STs of HUSEC collection (in orange), human STEC STs (in green) and STs from
other source that are identical to STs in our study (in blue) in E. coli MLST database. Each circle represents a given ST with the pie proportional to
number of isolates in a given ST from different sources. The numbers on connecting lines show the number of allelic difference between two STs. The
number in a circle is the ST number.
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http://www.biomedcentral.com/1471-2180/14/5Other virulence factors may contribute to the patho-
genicity of STEC. Although the role of EAST1 toxin in
virulence to pigs has not been clearly determined, sev-
eral studies have shown that astA gene is widely present
among STEC isolates from both diarrheal and healthy
pigs [15,24,26]. astA gene was also the most prevalent
virulent gene (53.76%) among the 20 virulence genes
tested in our study.
HPI was originally identified in Yersinia and now
found in a range of pathogens [51], including the HUS-
associated E. coli HUSEC041 [52] and the 2011 German
HUS outbreak strain O104:H4 [53]. HPI had previously
been detected in Stx2e- producing STEC strains from
humans only [19]. In this study we found 4 stx2e STEC
isolates, all ONT:H19/[H19], harbored the 2 HPI genes
fyuA and irp although the frequency is low at 4.3%.
Fimbrial adhesins play an important role in colonization
of the pig intestine and STEC strains may express up to 5
antigenically distinct fimbrial adhesins, F4, F5, F6, F18 and
F41 [18]. Different types of fimbriae can be associated with
STEC diarrhea in animals of different ages [15-18]. In this
study, only 4 isolates contained a fimbrial adhesin (F18).
None of the other fimbrial adhesins (F4, F5, F6, F17 and
F41) was detected. Of the nonfimbrial adhesin-encoding
genes, paa was found in 7 isolates (7.5%), but efa1, toxB,
lpfAO157/OI-154, lpfAO157/OI-141, lpfAO113 and saa were not
detected in any of the 93 STEC isolates. Eighty-two STEC
isolates did not carry any of the adherence-associated
genes tested.
Coombes et al. [54] reported that non-LEE encoded
T3SS effector (nle) genes of non-O157 STEC strains are
correlated with outbreak and HUS potential in humans.
It will be interesting to examine our STEC isolates for
the presence of the nle genes in future studies.
Many non-O157 STEC isolated from humans and
animals have shown resistance to multiple antimicro-
bials [26,55,56], including resistance to trimethoprim-
sulfamethoxazole and β-lactams [56,57]. STEC isolates
from swine feces in the United States show high resistance
rates (>38%) to tetracycline, sulfamethoxazole and kana-
mycin but susceptible to nalidixic acid (resistance rate
0.5%) [26]. In our study, we found that only 1 of the 12
categories of antimicrobial resistance types (carbapenems)
and 2 of the 23 antimicrobial agents (imipenem and
meropenem) were active against all the STEC isolates.
The high prevalence (>50%) of resistance to tetracycline,
trimethoprim-sulfamethoxazole, nalidixic acid and kana-
mycin is similar to that of other studies in China [55,58].
In a study [55] of STEC from diseased pigs in Guangdong
province, China, the majority of the isolates (95%) were re-
sistant to more than 3 antimicrobials and the resistance
rates to chloramphenicol (89%) and streptomycin (83%)
were far higher than that of our study (37.63% and
48.39%, respectively). We also found that isolates fromChongqing showed a higher rate than those from the
other 2 cities in this study. It should be noted that all
samples collected from Chongqing were fecal samples
while those from Beijing and Guizhou were small intes-
tinal contents and colon contents samples, which may
affect resistance profiles if different E. coli strains have a
preference for the anatomic sites. However, it is more
likely that the difference reflected the presence of resist-
ant E. coli strains in different regions. Chongqing was
dominated by the multidrug resistant ST3628. The dif-
ferences in drug resistance rates between cities may be
related to the differences in the prevalence of drug re-
sistant STs.
Comparison with STs observed in human infections
gives an indication of the potential risk for human infec-
tion of the swine STEC. We constructed an MST con-
taining our STs, the 32 STs of the HUSEC collection
and 52 human STEC STs from the E. coli MLST data-
base (Figure 3B). None of the 21 STs in this study was
identical to any of the 32 STs of HUSEC collection [52].
We only found one ST, ST993, which was observed in
human infections. When comparison was made at
clonal complex level, some of our STs fell into the same
clonal complex as the human STs (Figure 3B). ST10
clonal complex contained 2 of our STs (ST10 and
ST3628), 1 HUSEC ST (ST43) and 1 human STEC ST
(ST719) from the MLST database. However, Hauser
et al. found that 8 of the 35 STEC STs they isolated
from foods shared the same STs with HUSEC strains
and were similar in their virulence gene composition
[59]. Since the STECs from foods and HUSEC collec-
tion were from the same geographical region, it is likely
some of the HUSEC STECs were from local sources and
not globally distributed. Our STECs from pigs may
cause local human infections but there is no surveil-
lance of human STECs in the regions where we sampled
the swine STECs.Conclusions
In conclusion, the prevalence of STEC in healthy pigs is
high (25.42%) by PCR screening although only 6.18% of
the swine samples yielded an STEC isolate by microbio-
logical culture. The vast majority of isolates belonged to
a limited number of serogroups and serotypes, with
O20:H30/[H30] being the predominant serotype. The
majority of the STEC serotypes found in this study were
also reported in other countries. All 93 STEC isolates
carried the pig associated stx2e subtype. Only a small
proportion of the STEC isolates harbored hlyA, ehxA
and adhersin genes. Based on comparison by serotypes
and sequence types with human strains and presence of
virulence genes, the STEC isolated from pigs may have
a low potential to cause human disease. However,
Meng et al. BMC Microbiology 2014, 14:5 Page 10 of 14
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health significance in causing human disease in China.
Methods
Sample collection
A total of 1003 samples was collected from May 2011 to
August 2012, of which 326 were fecal samples collected
in pig farms in Chongqing city, 351 were small intestinal
contents and 326 were colon contents collected in pig
slaughter houses in Beijing city and Guizhou province.
Samples were transported as soon as possible to the la-
boratory in the National Institute for Communicable
Disease Control and Prevention, Chinese Center for
Disease Control and Prevention in ice-bags cold condi-
tions for the isolation of STEC.
Isolation of STEC
One gram of each sample was enriched in 5 ml of modi-
fied Tryptone Soya Broth (mTSB) supplemented with
novobiocin (10 mg/liter) (Oxoid, UK) and incubated at
37°C for 18 to 24 h with shaking at 200 rpm. Briefly,
150 μl of the lysis buffer (100 mM NaCl, 10 mM Tris–
HCl [pH 8.3], 1 mM EDTA [pH 9.0], 1% Triton X-100)
were added to the centrifuged enrichment sample, boiled
for 10 min and centrifuged. The supernatant was used
as template to test for the presence of stx1 and stx2 by
TaqMan duplex real time PCR assay developed by Bai et
al. [60]. One loopful of the stx-positive enrichment cul-
ture was directly streaked onto CHROMagar™ ECC plate
(CHROMagar, Microbiology, Paris, France). After over-
night incubation at 37°C, 10 blue or colorless, round
moist presumptive colonies on each plate were initially
picked randomly to test for the presence of stx1 and stx2
by conventional duplex PCR assay (primers listed in
Table 3) and another 10 colonies were picked if the ini-
tial 10 were negative for any of the stx genes. The stx-
positive colonies were plated onto Luria-Bertani (LB)
plates and incubated overnight for further identification.
One to 5 stx-positive isolates from each sample were
collected for further investigation.
Biochemical tests and serotyping of STEC isolates
All stx-containing isolates were confirmed to be E. coli
by using API 20E biochemical test strips (bioMérieux,
Lyon, France). Sorbitol fermentation characteristic was
examined by using sorbitol-MacConkey agar (SMAC)
(Oxoid, UK).
The hemolytic activity was tested by using sheep
blood agar (Oxoid, UK). The presence of transparent
zones around the colonies was interpreted as positive
hemolytic activity [71].
The determination of O antigens was firstly carried
out by testing for specific E. coli O groups of interest,
targeting group specific genes within the O-antigen genecluster described by DebRoy et al. [72]. The entire cod-
ing sequence of the fliC gene was amplified by PCR with
the primers fliC-F (5′-ATGGCACAAGTCATTAATA
CCCAAC-3′) and fliC-R (5′-CTAACCCTGCAGCA-
GAGACA-3′) reported by Fields et al. [73], and then
sequenced to determine the H type of each isolate.
In vitro motility was determined by inoculation of each
isolate in the center of motility agar plates (0.3% LB
agar) at 37°C for up to 48 h [74]. Bacterial motility was
assessed by examining the swimming ring. The O:H
serotype was confirmed by the O antisera and the H
antisera obtained from the Statens Serum Institut
(Copenhagen, Denmark).
stx subtyping
E. coli isolates were cultured in LB broth at 37ºC for 18–
24 h. DNA was extracted using Wizard Genomic DNA
Purification kits (Promega, USA). The presence of Shiga
toxin genes were assessed in all isolates by PCR using
primers targeting the stx1 and stx2 genes (Table 3) as de-
scribed by Brian et al. [61]. The stx2 subtypes were de-
termined by the PCR-based subtyping method devised
by Scheutz et al. [62]. The complete stx2 gene from a se-
lected set of STEC isolates was amplified using primers
GK1 and GK2 from Gunzer et al. [63] and sequenced to
verify the PCR-based subtyping results. The neighbor-
joining cluster analysis was employed to assign new sub-
types or variants as mentioned by Scheutz et al. [62].
Identification of virulence and adherence factors
All STEC isolates were tested by PCR to investigate the
presence of astA, hemolysis related genes (ehxA and
hlyA), HPI genes (fyuA and irp) and adhesion-related
genes (eae, paa, efa1, toxB, lpfAO157/OI-154, lpfAO157/OI-
141, lpfAO113, saa, F4, F5, F6, F17, F18 and F41) using
the primers listed in Table 3.
Antimicrobial susceptibility testing
Antimicrobial resistance was determined by the disc
diffusion method [75]. Twelve antimicrobial groups
covering 23 antimicrobial agents including penicillins
(ampicillin and piperacillin), β-lactam/β-lactamase in-
hibitor combinations (amoxicillin-clavulanic acid and
ampicillin-sulbactam), cephems (parenteral) (cephalospo-
rins I, II, III, and IV, cefepime, cefotaxime, ceftriaxone,
cephalothin and cefuroxime), monobactams (aztreonam),
carbapenems (imipenem and meropenem), aminogly-
cosides (gentamicin, kanamycin and streptomycin), te-
tracyclines (tetracycline), fluoroquinolones (ciprofloxacin,
norfloxacin and levofloxacin), quinolones (nalidixic acid),
folate pathway inhibitors (trimethoprim-sulfamethoxa-
zole), phenicols (chloramphenicol) and nitrofurans (nitro-
furantoinz) were tested. Results were interpreted using the
Clinical and Laboratory Standards Institute (CLSI, 2012)
Table 3 PCR primers used for the detection of STEC virulence or adherence genes
Targets Primer Oligonucleotide sequence (5′-3′) Amplicon size (bp) Reference
stx1 stx1-F AAATCGCCATTCGTTGACTACTTCT 370 [61]
stx1-R TGCCATTCTGGCAACTCGCGATGCA
stx2 stx2-F CAGTCGTCACTCACTGGTTTCATCA 283 [61]
stx2-R GGATATTCTCCCCACTCTGACACC
stx2e stx2e-F CGGAGTATCGGGGAGAGGC 411 [62]
stx2e-R CTTCCTGACACCTTCACAGTAAAGGT
SLT-II GK1 ATGAAGTGTATATTATTTAAATGG 1241 [63]
GK4 TCAGTCATTATTAAACTGCAC
ehxA ehxA-F GGTGCAGCAGAAAAAGTTGTAG 1551 [64]
ehxA-R TCTCGCCTGATAGTGTTTGGTA
hlyA hlyA1-F GACAAAGCACGAAAGATG 2930 [6]
hlyA2-R CAACTGCAATAAAGAAGC
astA EAST11a CCATCAACACAGTATATCCGA 111 [65]
EAST11b GGTCGCGAGTGACGGCTTTGT
irp2 irp2-F AAGGATTCGCTGTTACCGGAC 280 [66]
irp2-R TCGTCGGGCAGCGTTTCTTCT
fyuA fyuA-F TGATTAACCCCGCGACGGGAA 880 [66]
fyuA-R CGCAGTAGGCACGATGTTGTA
eae eae-F ACGTTGCAGCATGGGTAACTC 815 [36]
eae-R GATCGGCAACAGTTTCACCTG
paa M155-F1 ATGAGGAAACATAATGGCAGG 350 [67]
M155-R1 TCTGGTCAGGTCGTCAATAC
iha iha-F CAGTTCAGTTTCGCATTCACC 1305 [68]
iha-R GTATGGCTCTGATGCGATG
saa saa-F CGTGATGAACAGGCTATTGC 119 [14]
saa-R ATGGACATGCCTGTGGCAAC
toxB toxB-F ATACCTACCTGCTCTGGATTGA 602 [69]
toxB-R TTCTTACCTGATCTGATGCAGC
efa1 efa1-F GAGACTGCCAGAGAAAG 479 [11]
efa1-R GGTATTGTTGCATGTTCAG
lpfAO157/OI-154 lpfAO157/OI-154-F GCAGGTCACCTACAGGCGGC 525 [14]
lpfAO157/OI-154-R CTGCGAGTCGGCGTTAGCTG
lpfAO157/OI-141 lpfAO157/OI-141-F CTGCGCATTGCCGTAAC 412 [70]
lpfAO157/OI-141-R ATTTACAGGCGAGATCGTG
lpfAO113 lpfAO113-F ATGAAGCGTAATATTATAG 573 [9]
lpfAO113-R TTATTTCTTATATTCGAC
F4(K88) F4-F GCTGCATCTGCTGCATCTGGTATGG 792 [15]
F4-R CCACTGAGTGCTGGTAGTTACAGCC
F5(K99) F5-F TGCGACTACCAATGCTTCTG 450 [15]
F5-R TATCCACCATTAGACGGAGC
F6(P987) F6-F TCTGCTCTTAAAGCTACTGG 333 [15]
F6-R AACTCCACCGTTTGTATCAG
F17 F17-F GGGCTGACAGAGGAGGTGGGGC 411 [15]
F17-R CCCGGCGACAACTTCATCACCGG
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Table 3 PCR primers used for the detection of STEC virulence or adherence genes (Continued)
F18 F18-F GTGAAAAGACTAGTGTTTATTTC 510 [15]
F18-R CTTGTAAGTAACCGCGTAAGC
F41 F41-F GAGGGACTTTCATCTTTTAG 431 [15]
F41-R AGTCCATTCCATTTATAGGC
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used as quality control.PFGE and MLST
STEC isolates were digested with XbaI and separated by
PFGE using the non-O157 STEC PulseNet protocol
(www.pulsenetinternational.org). Gel images were con-
verted to Tiff files and then analyzed using BioNumerics
software (Applied Maths, Sint-Martens-Latem, Belgium).
MLST was performed according to the recommenda-
tions of the E. coli MLST website (http://mlst.ucc.ie/
mlst/dbs/Ecoli) using 7 housekeeping genes (adk, fumC,
gyrB, icd, mdh, purA and recA). Alleles and sequence
types (STs) were determined following the website in-
structions [76]. MLST data for the HUS-associated
enterohemorrhagic E. coli (HUSEC) collection were ob-
tained from www.ehec.org [52]. All human STEC STs
from the E. coli MLST databases were downloaded for
comparison. A minimum spanning tree based on these
STs was generated with BioNumerics software.
Four novel alleles, fumC470, gyrB351, icd396 and
recA267 were submitted to E. coli MLST website. The se-
quences obtained in this study have been deposited in Gen-
Bank: KC924398 (icd396), KC924399 (gyrB351), KC924400
(fumC470), KC924401 (recA267) and KC339670 (a new
variant of stx2e).Statistical analysis
Statistical tests were performed using SAS, Version 9.1
(SAS Institute Inc., Cary, NC., USA). Statistically signifi-
cant differences were calculated using a χ2 test where
appropriate. P values of <0.05 were considered statisti-
cally significant.Ethics statement
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